Indivior (LON:INDV) Shares Down 15.7% – What’s Next?

Indivior PLC (LON:INDV) shares were down 15.7% during trading on Thursday . The stock traded as low as GBX 548.71 ($6.93) and last traded at GBX 732 ($9.25). Approximately 1,888,371 shares traded hands during mid-day trading, an increase of 166% from the average daily volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.97).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($22.74) target price on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Price Performance

The firm has a market cap of £1.08 billion, a price-to-earnings ratio of -570.87, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The business has a 50 day simple moving average of GBX 920.11 and a 200-day simple moving average of GBX 850.81.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.